Valuation: Teva Pharmaceutical Industries Limited

Market Cap 44.9B 0 39.11B 37.01B 33.63B 62.82B 4,300B 63.13B 441B 170B 2,185B 169B 165B 6,996B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 56.32B 0 49.06B 46.43B 42.18B 78.81B 5,394B 79.19B 553B 214B 2,741B 212B 207B 8,776B EV / Sales 2026 *
3.37x
EV / Sales 2027 * 3.09x
Free-Float
91.2%
Yield 2026 *
-
Yield 2027 * -
1 day+1.36%
1 week+7.55%
Current month+11.67%
1 month+10.64%
3 months+25.43%
6 months+27.36%
Current year+18.53%
1 week 11,180
Extreme 11180
11,990
1 month 10,660
Extreme 10660
11,990
Current year 8,860
Extreme 8860
11,990
1 year 6,082
Extreme 6082
11,990
3 years 3,250
Extreme 3250
11,990
5 years 2,383
Extreme 2383
11,990
10 years 2,175
Extreme 2175
19,670
Manager TitleAgeSince
Chief Executive Officer 57 31/12/2022
Director of Finance/CFO 53 21/12/2019
Chief Operating Officer 52 02/06/2024
Director TitleAgeSince
Director/Board Member 69 31/12/2008
Chairman 78 05/02/2017
Director/Board Member 65 31/08/2015
Change 5-day change 1-year change 3-year change Capi.($)
+1.36%+7.55% - - 44.9B
+1.37%+2.06%+50.79%+100.63% 1,014B
+1.24%+1.01%+51.83%+65.59% 644B
+0.78%+3.29%+19.29%+71.10% 464B
-0.36%+4.54%+38.71%+40.03% 354B
+1.52%+3.46%+20.13%+26.08% 265B
+2.41%+5.70%+9.06%+15.85% 253B
+0.87%-1.19%+37.57%+43.61% 203B
+2.48%-2.43%-24.40%-57.05% 186B
+2.23%+3.59%+33.62%+98.37% 183B
Average +1.34%+0.96%+26.29%+44.91% 396.31B
Weighted average by Cap. +1.16%+1.41%+34.88%+61.30%

Financials

2026 *2027 *
Net sales 16.69B 0 14.54B 13.76B 12.5B 23.35B 1,598B 23.47B 164B 63.37B 812B 62.7B 61.3B 2,600B 17.33B 0 15.1B 14.29B 12.98B 24.25B 1,660B 24.37B 170B 65.81B 844B 65.11B 63.66B 2,701B
Net income 1.39B 0 1.21B 1.15B 1.04B 1.94B 133B 1.95B 13.64B 5.28B 67.63B 5.22B 5.1B 216B 2.46B 0 2.14B 2.03B 1.84B 3.45B 236B 3.46B 24.18B 9.35B 120B 9.25B 9.04B 384B
Net Debt 11.42B 0 9.95B 9.42B 8.56B 15.98B 1,094B 16.06B 112B 43.37B 556B 42.91B 41.96B 1,780B 8.66B 0 7.54B 7.14B 6.48B 12.11B 829B 12.17B 84.99B 32.86B 421B 32.52B 31.79B 1,349B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
17/09/26 ILA 11,960.00 +1.36% 1,562,605
16/09/26 ILA 11,800.00 +0.77% 1,135,971
15/09/26 ILA 11,710.00 +1.47% 1,124,143
14/09/26 ILA 11,540.00 +3.78% 950,706
10/09/26 ILA 11,120.00 -0.09% 1,052,520
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
38.53USD
Average target price
42.00USD
Spread / Average Target
+9.01%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!